Module

Hepatocellular Carcinoma

Source: Hepatitis Annual Update 2004

Hepatocellular Carcinoma


Program Director: John P. Phair, MD

Faculty:

  • Adrian M. Di Bisceglie, MD, FACP

CME CREDIT INFORMATION

Release Date: 09/10/04

Expiration Date: 09/09/05


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Outline the various treatment options available for HCC

  • List the various risk factors for HCC

  • Discuss the epidemiology of hepatocellular carcinoma (HCC) in the Unites States and abroad


Content includes:

  • Epidemiology
  • Risk Factors for HCC
  • Clinical Features and Diagnosis of HCC
  • Treatment Options for HCC
  • Screening and Preventing HCC
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.